333 related articles for article (PubMed ID: 23137910)
1. Transporter gene expression in human head and neck squamous cell carcinoma and associated epigenetic regulatory mechanisms.
Zolk O; Schnepf R; Muschler M; Fromm MF; Wendler O; Traxdorf M; Iro H; Zenk J
Am J Pathol; 2013 Jan; 182(1):234-43. PubMed ID: 23137910
[TBL] [Abstract][Full Text] [Related]
2. Expression and clinical significance of the Kv3.4 potassium channel subunit in the development and progression of head and neck squamous cell carcinomas.
Menéndez ST; Rodrigo JP; Allonca E; García-Carracedo D; Alvarez-Alija G; Casado-Zapico S; Fresno MF; Rodríguez C; Suárez C; García-Pedrero JM
J Pathol; 2010 Aug; 221(4):402-10. PubMed ID: 20593490
[TBL] [Abstract][Full Text] [Related]
3. RAR beta2 suppression in head and neck squamous cell carcinoma correlates with site, histology and age.
Olasz J; Juhász A; Remenár E; Engi H; Bak M; Csuka O; Kásler M
Oncol Rep; 2007 Jul; 18(1):105-12. PubMed ID: 17549354
[TBL] [Abstract][Full Text] [Related]
4. Positive correlation of tissue inhibitor of metalloproteinase-3 and death-associated protein kinase hypermethylation in head and neck squamous cell carcinoma.
Nayak CS; Carvalho AL; Jeronimo C; Henrique R; Kim MM; Hoque MO; Chang S; Jiang WW; Koch W; Westra W; Sidransky D; Califano J
Laryngoscope; 2007 Aug; 117(8):1376-80. PubMed ID: 17592394
[TBL] [Abstract][Full Text] [Related]
5. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA
Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
[TBL] [Abstract][Full Text] [Related]
6. Differential gene expression signature between primary and metastatic head and neck squamous cell carcinoma.
Liu CJ; Liu TY; Kuo LT; Cheng HW; Chu TH; Chang KW; Lin SC
J Pathol; 2008 Mar; 214(4):489-97. PubMed ID: 18213732
[TBL] [Abstract][Full Text] [Related]
7. Tumor suppressor activity of CCAAT/enhancer binding protein alpha is epigenetically down-regulated in head and neck squamous cell carcinoma.
Bennett KL; Hackanson B; Smith LT; Morrison CD; Lang JC; Schuller DE; Weber F; Eng C; Plass C
Cancer Res; 2007 May; 67(10):4657-64. PubMed ID: 17510391
[TBL] [Abstract][Full Text] [Related]
8. Expression profiles and clinical correlations of degradome components in the tumor microenvironment of head and neck squamous cell carcinoma.
Stokes A; Joutsa J; Ala-Aho R; Pitchers M; Pennington CJ; Martin C; Premachandra DJ; Okada Y; Peltonen J; Grénman R; James HA; Edwards DR; Kähäri VM
Clin Cancer Res; 2010 Apr; 16(7):2022-35. PubMed ID: 20305301
[TBL] [Abstract][Full Text] [Related]
9. Hypermethylation of collagen α2 (I) gene (COL1A2) is an independent predictor of survival in head and neck cancer.
Misawa K; Kanazawa T; Misawa Y; Imai A; Endo S; Hakamada K; Mineta H
Cancer Biomark; 2011-2012; 10(3-4):135-44. PubMed ID: 22674299
[TBL] [Abstract][Full Text] [Related]
10. Expression of CXCR4 and its down-regulation by IFN-gamma in head and neck squamous cell carcinoma.
Katayama A; Ogino T; Bandoh N; Nonaka S; Harabuchi Y
Clin Cancer Res; 2005 Apr; 11(8):2937-46. PubMed ID: 15837745
[TBL] [Abstract][Full Text] [Related]
11. Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma.
Masuda M; Suzui M; Yasumatu R; Nakashima T; Kuratomi Y; Azuma K; Tomita K; Komiyama S; Weinstein IB
Cancer Res; 2002 Jun; 62(12):3351-5. PubMed ID: 12067972
[TBL] [Abstract][Full Text] [Related]
12. Analysis of PIK3CA and Akt/protein kinase B in head and neck squamous cell carcinoma.
Fenic I; Steger K; Gruber C; Arens C; Woenckhaus J
Oncol Rep; 2007 Jul; 18(1):253-9. PubMed ID: 17549376
[TBL] [Abstract][Full Text] [Related]
13. Quantitative expression analysis of the apoptosis-related gene, BCL2L12, in head and neck squamous cell carcinoma.
Geomela PA; Kontos CK; Yiotakis I; Scorilas A
J Oral Pathol Med; 2013 Feb; 42(2):154-61. PubMed ID: 22747515
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic screen of human DNA repair genes identifies aberrant promoter methylation of NEIL1 in head and neck squamous cell carcinoma.
Chaisaingmongkol J; Popanda O; Warta R; Dyckhoff G; Herpel E; Geiselhart L; Claus R; Lasitschka F; Campos B; Oakes CC; Bermejo JL; Herold-Mende C; Plass C; Schmezer P
Oncogene; 2012 Dec; 31(49):5108-16. PubMed ID: 22286769
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of IFITM1 has clinicopathologic effects on gastric cancer and is regulated by an epigenetic mechanism.
Lee J; Goh SH; Song N; Hwang JA; Nam S; Choi IJ; Shin A; Kim IH; Ju MH; Jeong JS; Lee YS
Am J Pathol; 2012 Jul; 181(1):43-52. PubMed ID: 22609115
[TBL] [Abstract][Full Text] [Related]
16. Reduced promoter methylation and increased expression of CSPG4 negatively influences survival of HNSCC patients.
Warta R; Herold-Mende C; Chaisaingmongkol J; Popanda O; Mock A; Mogler C; Osswald F; Herpel E; Küstner S; Eckstein V; Plass C; Plinkert P; Schmezer P; Dyckhoff G
Int J Cancer; 2014 Dec; 135(11):2727-34. PubMed ID: 24740185
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-kappaB signaling as characteristics of a high-risk head and neck squamous cell carcinoma.
Chung CH; Parker JS; Ely K; Carter J; Yi Y; Murphy BA; Ang KK; El-Naggar AK; Zanation AM; Cmelak AJ; Levy S; Slebos RJ; Yarbrough WG
Cancer Res; 2006 Aug; 66(16):8210-8. PubMed ID: 16912200
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen activator inhibitor-2: a molecular biomarker for head and neck cancer progression.
Hasina R; Hulett K; Bicciato S; Di Bello C; Petruzzelli GJ; Lingen MW
Cancer Res; 2003 Feb; 63(3):555-9. PubMed ID: 12566295
[TBL] [Abstract][Full Text] [Related]
19. Identification of molecular targets in head and neck squamous cell carcinomas based on genome-wide gene expression profiling.
Shimizu S; Seki N; Sugimoto T; Horiguchi S; Tanzawa H; Hanazawa T; Okamoto Y
Oncol Rep; 2007 Dec; 18(6):1489-97. PubMed ID: 17982635
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profiling of head and neck squamous cell carcinoma using cDNA microarrays.
Gottschlich S; Ambrosch P; Cordes C; Görögh T; Schreiber S; Häsler R
Int J Oncol; 2006 Sep; 29(3):605-13. PubMed ID: 16865276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
